Coming Soon
Bymetric is Launching Soon
Open main menu
Innovate UK Funded
Public Funded Companies
Spinout Companies
News
Register
Login
View notifications
Innovate UK Funded
Spinout Companies
New Companies
News
Hubspot Companies House Data
Register
Login
Phoremost focuses on drug discovery and development, utilizing advanced computational methods to identify new drug targets and optimize lead compounds for various diseases.
phoremost.com
LinkedIn
Twitter
Spinout Company
Public Funding Received
2017-07-01
A novel small molecule approach to enhance cancer immunotherapy
Collaborative R&D
2017-05-01
UDS: A novel discovery tool for positive selection of signalling pathway inhibitors
Collaborative R&D
2015-04-01
Targeting KRAS mutant cancers using a novel inhibitor of PLK1 substrate binding
Collaborative R&D